Fda: no correlation between Johnson & Johnson vaccine and thrombosis

In line to receive Johnson & Johnson vaccine in Philadelphia (AP Photo / Matt Rourke)

• In France, the second dose for those under 55 will not be AstraZeneca but another vaccine

• Son: "No problem with second dose, it will be with Astrazeneca vaccine"

• Ema evaluates AstraZeneca's link with another rare disorder and initiates Janssen review after 4 thromboembolism

Share

April 10, 2021 Food and Drug Administration "found no causal relationship" between Johnson & Johnson serum vaccination and thrombosis cases.

This was reported by Reuters on its website citing a communication from the regulatory body for drugs in the States sent by email.

According to the note, the "FDA is aware of cases of people with severe blood clots - sometimes linked to low blood platelet levels - after the administration of J&J" and stressed "that these conditions can have many different causes" , stating that it will continue to investigate.